Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Potassium channels in vascular smooth muscle are a diverse family of ion channels that play a central role in controlling vascular tone, blood vessel diameter, and blood pressure by regulating the membrane potential of vascular smooth muscle cells[1][2][4][5][6]. At least five classes are recognized: large-conductance Ca²⁺-activated (BKCa), intermediate/small conductance Ca²⁺-activated (IKCa/SKCa), voltage-gated (KV), ATP-sensitive (KATP), inward rectifier (Kir), and tandem two-pore (K2P) channels[2][6][1]. Their activation leads to K⁺ efflux, membrane hyperpolarization, closure of voltage-dependent Ca²⁺ channels, and vasodilation, while their inhibition results in membrane depolarization, increased Ca²⁺ influx, and vasoconstriction[4][2][1]. These channels are thus fundamental regulators of vascular reactivity and blood pressure and are implicated in a range of disease states including hypertension, atherosclerosis, diabetes, and vascular proliferative disorders[2][5][4]. Potassium channels are validated therapeutic targets, with pharmacological openers (e.g., minoxidil, diazoxide, pinacidil) and blockers (e.g., glibenclamide, 4-AP, tetraethylammonium) in clinical or investigative use for cardiovascular and other indications[2][3][7]. Targeting these channels carries the risk of dysregulated vascular tone and arrhythmias due to shared channel subtypes among tissues[3][4][2].
Channel activation causes membrane hyperpolarization, closure of voltage-dependent calcium channels, decreased intracellular Ca²⁺, and vasodilation; Channel inhibition causes membrane depolarization, opening of calcium channels, increased Ca²⁺ influx, and vasoconstriction; Proliferation control through modulation of membrane potential and signaling pathways
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium channel in vascular smooth muscle.